Brenda E Porter, MD
Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Porter’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G89267 · Current
Licensed to practise in California · since 2012 · expires 2026-10-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$13,882 in 2024
Medicaid paid $13,882 for 76 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 49 | $10,986 |
| Return visit (30+ min) | 27 | $2,896 |
| 2024 | 76 | 2 | 17 | $13,882 |
| 2023 | 70 | 2 | 18 | $6,727 |
| 2022 | 66 | 3 | 14 | $9,253 |
| 2021 | 177 | 3 | 23 | $25,500 |
| 2020 | 86 | 2 | 16 | $10,522 |
| 2019 | 45 | 2 | 13 | $10,135 |
| 2018 | 138 | 2 | 21 | $16,461 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 46 | $3,688 |
| Long return visit (40+ min) | 24 | $3,039 |
2022
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 21 | $4,229 |
| Long return visit (40+ min) | 33 | $3,998 |
| Return visit (30+ min) | 12 | $1,026 |
2021
| Long return visit (40+ min) | 96 | $11,833 |
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 49 | $10,819 |
| Return visit (30+ min) | 32 | $2,848 |
2020
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 19 | $5,331 |
| Return visit (30+ min) | 67 | $5,191 |
2019
| Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours | 33 | $8,883 |
| Long return visit (40+ min) | 12 | $1,252 |
2018
| Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours | 38 | $10,240 |
| Return visit (30+ min) | 100 | $6,222 |
Drugs they prescribed that Part D paid
$26,952
Pharmacies billed $26,952 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 61) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
55 generic and fewer than 11 brand-name prescriptions · $26,952 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levocarnitine | 14 | $1,391 | $99 |
Year by year
| 2024 | 61 | None | 0% (0) | None | $26,952 |
| 2023 | 39 | None | 0% (0) | 0% | $4,072 |
| 2020 | 14 | None | 0% (0) | None | $12,390 |
| 2019 | 11 | None | 0% (0) | None | $11,898 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$66 in 2025
| 2025 | 1 | 1 | None | $66 |
| 2024 | 1 | 1 | None | $46 |
| 2020 | 1 | 1 | $957 | $957 |
| 2019 | 1 | 1 | $1,401 | $1,401 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | Epidiolex | $66 | 1 payment
|
See the published payment
| Jazz Pharmaceuticals | Meals · 2025-12-07 | Epidiolex | $66 |
See earlier years (2024, 2020, 2019)
2024: $46
| Jazz Pharmaceuticals | Epidiolex | $46 | 1 payment
|
2020: $957
| Jazz Pharmaceuticals | None | $957 | 1 payment
|
2019: $1,401
| Jazz Pharmaceuticals | None | $1,401 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Eisai Inc. · A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With An Open-Label Extension Phase of Perampanel As Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome · 2021 | Their institution | $138,909 |
| Eisai Inc. · A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With An Open-Label Extension Phase of Perampanel As Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome · 2019 | Their institution | $112,586 |
| Eisai Inc. · A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With An Open-Label Extension Phase of Perampanel As Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome · 2020 | Their institution | $90,005 |
| SK Life Science, Inc. · Ykp509c003 · 2024 | Their institution | $64,287 |
| SK Life Science, Inc. · Ykp509c003 · 2025 | Their institution | $52,703 |
| SK Life Science, Inc. · Ykp509c003 · 2023 | Their institution | $37,795 |
| Eisai Inc. · An Open-Label, Multicenter Study With An Extension Phase To Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered As An Adjunctive Therapy in Pediatric Subjects (Age 4 To Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures Or Primary Generalized Tonic Clonic Seizures · 2019 | Their institution | $21,218 |
| NEUROPACE, INC. · Retro Chart Review for Under 18 Patients Study · 2019 | This clinician | $3,000 |
Professional record
- NPI
- 1346256583
- Licence
- CA G89267California G89267: Current · expires 2026-10-31
- Trained
- University of Washington School of Medicine, 1995
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- NJ 8904502
- Taxonomy
- Federal specialty code 2084N0402X (2084N0402X); Pediatrics (208000000X); Federal specialty code 2084E0001X (2084E0001X); Federal specialty code 2084N0600X (2084N0600X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-07-31
- NPI last updated
- 2023-11-13
- NPI record certified
- 2023-11-13
This is when the NPI record was last certified, not a medical board exam.